Oncolytics Biotech Files February 2025 6-K Report
Ticker: ONCY · Form: 6-K · Filed: Feb 18, 2025 · CIK: 1129928
Sentiment: neutral
Topics: reporting, foreign-private-issuer, sec-filing
Related Tickers: ONCO
TL;DR
ONCO files routine Feb 2025 6-K, no major news yet.
AI Summary
Oncolytics Biotech Inc. filed a Form 6-K on February 18, 2025, reporting for the month of February 2025. The company, based in Calgary, Alberta, Canada, is a foreign private issuer and will file its annual reports under Form 20-F. The filing does not appear to contain specific financial figures or operational updates beyond its routine reporting status.
Why It Matters
This filing indicates Oncolytics Biotech Inc. is continuing its regular reporting as a foreign private issuer, which is standard for companies listed on US exchanges but based internationally.
Risk Assessment
Risk Level: low — This is a routine filing by a foreign private issuer and does not contain new material information that would typically impact risk.
Key Players & Entities
- Oncolytics Biotech Inc. (company) — Registrant
- February 2025 (date) — Reporting period
- 20250218 (date) — Filing date
- 001-38512 (other) — SEC File Number
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers that provides information which the issuer makes or is required to make public pursuant to the laws of its home country, or which it furnishes or makes public to its security holders.
Which annual report form does Oncolytics Biotech Inc. file?
Oncolytics Biotech Inc. files its annual reports under cover of Form 20-F.
What is the principal executive office address for Oncolytics Biotech Inc.?
The principal executive offices are located at Suite 804, 322 11th Avenue SW, Calgary, Alberta, Canada T2R 0C5.
What is the SIC code for Oncolytics Biotech Inc.?
The Standard Industrial Classification (SIC) code for Oncolytics Biotech Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Does this Form 6-K filing contain specific financial updates or operational news?
Based on the provided text, this Form 6-K appears to be a routine report for the month of February 2025 and does not detail specific financial figures or new operational developments.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on February 18, 2025 regarding ONCOLYTICS BIOTECH INC (ONCY).